Back | Next |
home / stock / cur / cur message board
Subject | By | Source | When |
---|---|---|---|
Whats the scoop here. My buddy introduced me yesterday. | MacBoys | investorshub | 12/18/2020 3:11:25 PM |
CUR used to have a drug in clinical | BesaoT35 | investorshub | 12/17/2020 9:24:34 PM |
Add the dips | Triple nickle | investorshub | 07/29/2020 2:34:50 PM |
Nice pop today | Triple nickle | investorshub | 07/21/2020 6:36:37 PM |
Looks like the Patent news was well-received. | HFM2 | investorshub | 07/07/2020 6:18:58 PM |
Adding dips and highs | Triple nickle | investorshub | 06/24/2020 9:07:01 PM |
Unreal...$520.00 pps target vs. >60,000% upside from $0.80 | 0210 | investorshub | 06/24/2020 8:40:48 PM |
Former Director Richard Garr just came on the | RiseandShine | investorshub | 06/10/2020 6:21:33 PM |
Adding again theyll Co over shortly | Triple nickle | investorshub | 06/08/2020 5:50:38 PM |
https://finance.yahoo.com/news/seneca-biopharma-announces-closing-5-150000484.ht | Exotico87 | investorshub | 06/08/2020 4:33:41 PM |
snca in @ 1.03 | WallStGhost | investorshub | 05/28/2020 3:25:57 PM |
* * $SNCA Video Chart 05-21-2020 * * | ClayTrader | investorshub | 05/21/2020 8:37:21 PM |
good Volume | beambe | investorshub | 05/21/2020 8:14:49 PM |
$1.09 nice | wesley_ | investorshub | 05/21/2020 4:34:50 PM |
nHOD $2.14 nice | wesley_ | investorshub | 05/21/2020 3:48:05 PM |
snca out @ 1.62 +6.57% https://twitter.com/WallStGhost/status/126347626723774055 | WallStGhost | investorshub | 05/21/2020 2:26:36 PM |
snca in @ 1.52 | WallStGhost | investorshub | 05/21/2020 2:22:01 PM |
30M+ traded in first hour! with less than | 10stars | investorshub | 05/21/2020 2:19:16 PM |
https://investorshub.advfn.com/boards/read msg.aspx?message id=155769676&txt2fin | TheFinalCD | investorshub | 05/21/2020 2:17:13 PM |
$1.80 nice | wesley_ | investorshub | 05/21/2020 1:48:38 PM |
News, Short Squeeze, Breakout and More Instantly...
RADNOR, Pa., March 19, 2021 (GLOBE NEWSWIRE) -- NeuroRx, Inc. announced the first patient in its P2/3 study of inhaled ZYESAMI™ in the treatment of moderate and severe COVID-19 (AVICOVID-2) was dosed at the University of California Irvine. The trial will be conducted at 10-15 clinica...
GERMANTOWN, Md. , Sept. 2, 2020 /PRNewswire/ -- Seneca Biopharma, Inc. (Nasdaq: SNCA), a biopharmaceutical company focused on developing novel treatments for diseases of high unmet medical need, today provided the following letter from Dr. Ken Carter , the Company's Executive Chairm...
GERMANTOWN, Md. , May 27, 2020 /PRNewswire/ -- Seneca Biopharma, Inc. (Nasdaq:SNCA), a clinical-stage biopharmaceutical company developing novel treatments for various diseases of high unmet medical need, today announced the closing of its previously announced $5 million registered...